Sanofi in Deal to Develop Autoimmune Drugs
By

By
Sanofi has signed an agreement with ImmuNext, a biopharmaceutical company headquartered in Lebanon, New Hampshire, to develop an antibody with potential to treat a range of autoimmune diseases including lupus…

Allergan Signs Deals for GI and Neurological Diseases
By

By
Allergan has entered two deals, one for gastrointestinal (GI) drug development and another for development of drugs to treat neurological diseases. The company formed the GI collaboration with Assembly Biosciences,…

Amgen in $530-Million Deal for Bispecific Immunotherapies
By

By
Amgen has formed a research collaboration and license agreement with Immatics Biotechnologies, a clinical-stage biopharmaceutical company based in Tuebingen, Germany and Houston, Texas, to develop T-cell engaging bispecific immunotherapies targeting…

Celgene in Pact to Develop Autoimmune Drugs
By

By
Celgene Switzerland, an affiliate of Celgene, has formed a research collaboration with Anokion, a privately held biopharmaceutical company headquartered in Préverenges, Switzerland to develop drugs for treating autoimmune diseases. Under…

Mylan to Acquire OTC Cold Remedy
By

By
Mylan has agreed to acquire global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, a Doylsetown, Pennsylvania-based distributor of over-the-counter (OTC) cold remedies and consumer products. The…

Teva Completes Sale of Actavis’ UK, Ireland Assets
By

By
Teva Pharmaceutical Industries has completed the previously announced sale of the majority of the assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited, a…

Merck & Co. to Develop Cancer Drug Combo Therapy
By

By
Merck & Co. has decided to advance a clinical development program for which it is partnered with Incyte Corporation, a Wilmington, Delaware-headquartered biopharmaceutical company, to investigate the combination of epacadostat,…

Daiichi Sankyo, Kite in Immuno-Oncology Pact
By

By
Daiichi Sankyo has formed a partnership in Japan with Kite Pharma, a clinical-stage biopharmaceutical company headquartered in Santa Monica, California, for Kite’s lead product candidate, axicabtagene ciloleucel (formerly KTE-C19), an…

Kite Forms Immuno-Oncology Joint Venture
By

By
Kite Pharma, a clinical-stage biopharmaceutical company headquartered in Santa Monica, California, and Shanghai Fosun Pharmaceutical (Group), a healthcare group in China, have formed a joint venture in China, Fosun Pharma…

Catalent in Softgel Deal
By

By
Catalent Pharma Solutions, a Somerset, New Jersey-based drug-delivery technology company, has entered into an agreement with Jupiter Orphan Therapeutics (JOT), a Jupiter, Florida-based clinical-stage specialty pharmaceutical company, to develop a…